These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 34499723)

  • 1. Impact of SMART Pass filter in patients with ajmaline-induced Brugada syndrome and subcutaneous implantable cardioverter-defibrillator eligibility failure: results from a prospective multicentre study.
    Conte G; Cattaneo F; de Asmundis C; Berne P; Vicentini A; Namdar M; Scalone A; Klersy C; Caputo ML; Demarchi A; Özkartal T; Salghetti F; Casu G; Passarelli I; Mameli S; Shah D; Burri H; De Ferrari G; Brugada P; Auricchio A
    Europace; 2022 May; 24(5):845-854. PubMed ID: 34499723
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High rate of subcutaneous implantable cardioverter-defibrillator sensing screening failure in patients with Brugada syndrome: a comparison with other inherited primary arrhythmia syndromes.
    Conte G; Kawabata M; de Asmundis C; Taravelli E; Petracca F; Ruggiero D; Caputo ML; Regoli F; Chierchia GB; Chiodini A; Del Bufalo A; Moccetti T; Goya M; Hirao K; Vicentini A; De Ferrari GM; Brugada P; Auricchio A
    Europace; 2018 Jul; 20(7):1188-1193. PubMed ID: 28340026
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Usefulness of subcutaneous implantable cardioverter-defibrillator therapy in patients with Brugada syndrome.
    Shinohara T; Abe I; Hirota K; Kondo H; Fukui A; Akioka H; Teshima Y; Yufu K; Nakagawa M; Takahashi N
    Heart Vessels; 2021 Feb; 36(2):260-266. PubMed ID: 32833119
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of electrocardiogram screening during drug challenge test for the prediction of T-wave oversensing by a subcutaneous implantable cardioverter defibrillator in patients with Brugada syndrome.
    Kamakura T; Wada M; Ishibashi K; Inoue YY; Miyamoto K; Okamura H; Nagase S; Noda T; Aiba T; Yasuda S; Kusano K
    Heart Vessels; 2017 Oct; 32(10):1277-1283. PubMed ID: 28523371
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Subcutaneous implantable cardioverter defibrillator eligibility according to a novel automated screening tool and agreement with the standard manual electrocardiographic morphology tool.
    Francia P; Ziacchi M; De Filippo P; Viani S; D'Onofrio A; Russo V; Adduci C; Biffi M; Ferrari P; Bianchi V; Ammendola E; Palano F; Frisoni J; Valsecchi S; Lovecchio M; Bongiorni MG
    J Interv Card Electrophysiol; 2018 Jun; 52(1):61-67. PubMed ID: 29502193
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of diurnal variations in the QRS complex and T waves on the eligibility for subcutaneous implantable cardioverter-defibrillators.
    Miwa N; Nagata Y; Yamaguchi T; Nagase M; Sasaki T; Nozato T; Ashikaga T; Goya M; Hirao K
    Heart Rhythm; 2019 Jun; 16(6):913-920. PubMed ID: 30616021
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Subcutaneous versus transvenous implantable cardioverter-defibrillator among drug-induced type-1 ECG pattern Brugada syndrome: a propensity score matching analysis from IBRYD study.
    Russo V; Caturano A; Guerra F; Migliore F; Mascia G; Rossi A; Nesti M; Santobuono VE; Attena E; Tola G; Sciarra L; Conte G; Paoletti Perini A; Francia P; Dendramis G; Palamà Z; Albani S; Ottonelli Ghidini A; Calò L; D'Onofrio A; Baldi E;
    Heart Vessels; 2023 May; 38(5):680-688. PubMed ID: 36418560
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Brugada syndrome: Eligibility for subcutaneous implantable cardioverter-defibrillator after exercise stress test.
    von Hafe P; Faria B; Dias G; Cardoso F; Alves MJ; Alves A; Rodrigues B; Ribeiro S; Sanfins V; Lourenço A
    Rev Port Cardiol (Engl Ed); 2021 Jan; 40(1):33-38. PubMed ID: 33436324
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surface Electrocardiogram Screening for Subcutaneous Implantable Cardioverter-Defibrillators in Japanese Patients With and Without Brugada Syndrome.
    Kawabata M; Goya M; Sasaki T; Maeda S; Yagishita A; Shirai Y; Kaneko M; Shiohira S; Isobe M; Hirao K
    Circ J; 2017 Jun; 81(7):981-987. PubMed ID: 28367844
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of an electrocardiographic screening tool to determine candidacy for a subcutaneous implantable cardioverter-defibrillator.
    Groh CA; Sharma S; Pelchovitz DJ; Bhave PD; Rhyner J; Verma N; Arora R; Chicos AB; Kim SS; Lin AC; Passman RS; Knight BP
    Heart Rhythm; 2014 Aug; 11(8):1361-6. PubMed ID: 24755323
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation of intracardiac electrogram with surface electrocardiogram in Brugada syndrome patients.
    Probst V; Sacher F; Derval N; Gourraud JB; Mabo P; Medkour F; Le Marec H; Gill J
    Europace; 2014 Jun; 16(6):908-13. PubMed ID: 24068444
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exercise stress test reveals ineligibility for subcutaneous implantable cardioverter defibrillator in patients with Brugada syndrome.
    Tachibana M; Nishii N; Morita H; Nakagawa K; Watanabe A; Nakamura K; Ito H
    J Cardiovasc Electrophysiol; 2017 Dec; 28(12):1454-1459. PubMed ID: 28800177
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictors of inappropriate shock in Brugada syndrome patients with a subcutaneous implantable cardiac defibrillator.
    Casu G; Silva E; Bisbal F; Viola G; Merella P; Lorenzoni G; Motta G; Bandino S; Berne P
    J Cardiovasc Electrophysiol; 2021 Jun; 32(6):1704-1711. PubMed ID: 33928706
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of type 1 Brugada ECG pattern after administration of Class 1C drugs in patients with type 1 myotonic dystrophy: Myotonic dystrophy as a part of the Brugada syndrome.
    Maury P; Audoubert M; Cintas P; Rollin A; Duparc A; Mondoly P; Chiriac AM; Acket B; Zhao X; Pasquié JL; Cardin C; Delay M; Sadron M; Carrié D; Galinier M; Davy JM; Arne-Bès MC; Raczka F
    Heart Rhythm; 2014 Oct; 11(10):1721-7. PubMed ID: 25016148
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of subcutaneous implantable cardioverter-defibrillator candidacy based on template ECG screening in patients with hypertrophic cardiomyopathy.
    Maurizi N; Olivotto I; Olde Nordkamp LR; Baldini K; Fumagalli C; Brouwer TF; Knops RE; Cecchi F
    Heart Rhythm; 2016 Feb; 13(2):457-63. PubMed ID: 26362577
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lights and shadows of subcutaneous implantable cardioverter-defibrillator in Brugada syndrome.
    Dendramis G; Brugada P
    Heart Rhythm; 2023 Feb; 20(2):274-281. PubMed ID: 36162769
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spatial and temporal heterogeneity of depolarization and repolarization may complicate implantable cardioverter defibrillator therapy in Brugada syndrome.
    Stix G; Bella PD; Carbucicchio C; Schmidinger H
    J Cardiovasc Electrophysiol; 2000 May; 11(5):516-21. PubMed ID: 10826930
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug-induced brugada syndrome in children: clinical features, device-based management, and long-term follow-up.
    Conte G; Dewals W; Sieira J; de Asmundis C; Ciconte G; Chierchia GB; Di Giovanni G; Baltogiannis G; Saitoh Y; Levinstein M; La Meir M; Wellens F; Pappaert G; Brugada P
    J Am Coll Cardiol; 2014 Jun; 63(21):2272-9. PubMed ID: 24681144
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predicting cardiac electrical response to sodium-channel blockade and Brugada syndrome using polygenic risk scores.
    Tadros R; Tan HL; ; El Mathari S; Kors JA; Postema PG; Lahrouchi N; Beekman L; Radivojkov-Blagojevic M; Amin AS; Meitinger T; Tanck MW; Wilde AA; Bezzina CR
    Eur Heart J; 2019 Oct; 40(37):3097-3107. PubMed ID: 31504448
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel CineECG Derived From Standard 12-Lead ECG Enables Right Ventricle Outflow Tract Localization of Electrical Substrate in Patients With Brugada Syndrome.
    van Dam PM; Locati ET; Ciconte G; Borrelli V; Heilbron F; Santinelli V; Vicedomini G; Monasky MM; Micaglio E; Giannelli L; Mecarocci V; Ćalović Ž; Anastasia L; Pappone C
    Circ Arrhythm Electrophysiol; 2020 Sep; 13(9):e008524. PubMed ID: 32755392
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.